Each year, the FDA approves a wide range of drugs spanning across conditions and therapeutic areas. Of the 55 drugs that received FDA-approval in 2023, we have compiled a list of the 10 most innovative and groundbreaking drugs – notably in the areas of Oncology, Immunology, Infectious Diseases among others. This report by Healthark Insights captures critical information around these drug innovations as well as the impact they’re anticipated to have on the future of Healthcare.